Does Buspirone Cause Insomnia?
Yes, buspirone can cause insomnia as a documented adverse effect, occurring in approximately 3% of patients in controlled clinical trials, and the drug may have stimulant properties that can disrupt sleep rather than promote it. 1
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for buspirone clearly lists insomnia as an adverse event occurring in 3% of buspirone-treated patients versus 3% in placebo in controlled clinical trials 1. More importantly, insomnia was identified as one of the primary reasons for drug discontinuation in premarketing trials, falling under "central nervous system disturbances" that caused 3.4% of patients to stop treatment 1.
Mechanism: Stimulant Rather Than Sedative Properties
Unlike benzodiazepines and other traditional anxiolytics, buspirone lacks sedative effects and may actually have stimulant properties 2. This is a critical distinction:
- Sleep laboratory studies in insomnia patients demonstrated that buspirone 10 mg at bedtime caused a marked and significant increase in wake time after sleep onset, particularly on the first night of administration 2
- The study concluded that buspirone has "limited usefulness in anxious patients with concomitant sleep difficulties" 2
- Animal studies corroborate this, showing buspirone increases wakefulness, decreases non-REM sleep, and can obliterate REM sleep at therapeutic doses 3, 4
Clinical Implications
If you have a patient with anxiety who also complains of insomnia, buspirone is a poor choice. The drug's mechanism of action—binding to serotonin 5-HT1A receptors and dopamine receptors—does not promote sleep and may actively interfere with it 1, 2.
Key Clinical Considerations:
- Timing matters: The stimulant effects are most pronounced in the first few hours after administration 2, 4
- Dose-dependent: Higher doses (10-20 mg) show more pronounced sleep disruption 3, 4
- Persistent effect: Sleep difficulties may continue with ongoing use, not just initially 2
Common Pitfall to Avoid
Do not assume that because buspirone is an anxiolytic, it will help with anxiety-related insomnia. The opposite may occur—you may successfully treat the anxiety but worsen the sleep problem. If both conditions require treatment, consider:
- Using buspirone for daytime anxiety dosing only (not at bedtime)
- Selecting an alternative anxiolytic with neutral or sedating properties if nighttime dosing is needed
- Addressing insomnia separately with evidence-based treatments (cognitive behavioral therapy for insomnia, or medications like eszopiclone, zolpidem, or suvorexant per AASM guidelines) 5
Additional Safety Signals
Recent pharmacovigilance data from the FAERS database identified anxiety (n=133) and nervous system disorders as the most common adverse events with buspirone, with a median time to onset of 10 days 6. This reinforces that CNS-activating effects, including sleep disruption, are clinically significant concerns with this medication.